Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 505 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 147 companies achieved new lows for the year.
Attention Biotech Investors: Mark Your Calendar For These Key February PDUFA Dates
After a fairly robust 2021, the new year started on a mixed note as far as regulatory decisions are concerned.
From Benzinga’s Global Small Cap Conference: Yield10 Biosciences President & CEO, Oliver Peoples Says Co’s Cash Reserves Will Take The Company Through Until 2023
https://www.youtube.com/watch?v=XkOilNZqoEIhttps://www.youtube.com/watch?v=XkOilNZqoEI
From Benzinga’s Global Small Cap Conference: Amryt Pharma CFO & COO, Rory Nealon Begins Presenting
https://www.youtube.com/watch?v=XkOilNZqoEI
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers
Pasithea Therapeutics (NASDAQ:KTTA) stock moved upwards by 228.5% to $7.26 during Tuesday's regular session. The company's market cap stands at $95.8 million.
Amryt’s Skin Disorder Drug Application Review With FDA Extended By Three Months
The FDA made a three-month extension to the review period for Amryt Pharma Plc's (NASDAQ:
SVB Leerink Maintains Outperform on Amryt Pharma, Lowers Price Target to $19
SVB Leerink analyst Mani Foroohar maintains Amryt Pharma (NASDAQ:AMYT) with a Outperform and lowers the price target from $23 to $19.
Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell
• R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.